The “Parkinson Foundation” honors scientists of the University Medical Center Göttingen for their project proposal “Glycation of alpha-synuclein as biomarker” with the Innovation Award in the category “Basic Research”. The Innovation Prize is endowed with 100 000 euros.
Dr. Annekatrin König, research associate, and Prof. Dr. Tiago Fleming Outeiro, MBExC member and director of the Department of Experimental Neurodegeneration at the University Medical Center Göttingen (UMG), have been awarded the Innovation Prize in the category “Basic Research” by the “Parkinson Foundation”. The scientists received the award for designing a study to investigate sugar-modified alpha-synuclein. Alpha-synuclein is a protein that plays a role in the development and progression of Parkinson’s disease. The award was given for the first time ever and presented online during the Foundation’s Parkinson’s Day on April 7, 2022.